{"url":"https://lda.senate.gov/api/v1/filings/622c8daa-de3f-40ef-bc00-087e4c55bbfc/","filing_uuid":"622c8daa-de3f-40ef-bc00-087e4c55bbfc","filing_type":"1A","filing_type_display":"1st Quarter - Amendment","filing_year":2023,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/622c8daa-de3f-40ef-bc00-087e4c55bbfc/print/","filing_document_content_type":"text/html","income":"65500.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Rachael Galoob","dt_posted":"2023-04-17T15:36:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"700 Pennsylvania Ave SE","registrant_address_2":"2nd Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":401104378,"url":"https://lda.senate.gov/api/v1/registrants/401104378/","house_registrant_id":null,"name":"THE LIAISON GROUP, LLC","description":"Lobbying firm focused on federal reform for the cannabis industry","address_1":"700 Pennsylvania Ave SE","address_2":"2nd Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RACHAEL GALOOB","contact_telephone":"+1 202-607-0226","dt_updated":"2026-07-27T18:55:40.444289-04:00"},"client":{"id":201639,"url":"https://lda.senate.gov/api/v1/clients/201639/","client_id":51,"name":"NATIONAL CANNABIS ROUNDTABLE","general_description":"Trade Association","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-03-06"},"lobbying_activities":[{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"Ensuring cannabis businesses have access to financial services (in former Congresses the SAFE Banking Act)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65840,"prefix":null,"prefix_display":null,"first_name":"RACHAEL","nickname":null,"middle_name":null,"last_name":"GALOOB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72496,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MANGONE","suffix":"esq","suffix_display":"ESQ"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"Allowing District of Columbia to have autonomy on issues of creating a regulated cannabis marketplace","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65840,"prefix":null,"prefix_display":null,"first_name":"RACHAEL","nickname":null,"middle_name":null,"last_name":"GALOOB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72496,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MANGONE","suffix":"esq","suffix_display":"ESQ"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Working on appropriations provisions that prevent the Department of Justice from interfering in state legal cannabis programs (both medical and adult use), allowing JAG Bryne funding to be used for expungements, banking language, various language proposals allowing veterans to access cannabis, fairness in federal drug testing, language protecting tribal sovereignty on cannabis decisions, and language promoting further research into cannabis.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65840,"prefix":null,"prefix_display":null,"first_name":"RACHAEL","nickname":null,"middle_name":null,"last_name":"GALOOB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72496,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MANGONE","suffix":"esq","suffix_display":"ESQ"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Bills to reduce criminal penalties of cannabis possession and distribution, including but not limited to for bills that remove cannabis from the Schedules in the Controlled Substances Act. Also active on provisions that would facilitate expungements of cannabis offenses including the Misdemeanor Expungement Act and the HOPE Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65840,"prefix":null,"prefix_display":null,"first_name":"RACHAEL","nickname":null,"middle_name":null,"last_name":"GALOOB","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72496,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MANGONE","suffix":"esq","suffix_display":"ESQ"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and hemp-derived intoxicating products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72496,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MANGONE","suffix":"esq","suffix_display":"ESQ"},"covered_position":"Charlie Rangel March 2016- December 2016","new":true},{"lobbyist":{"id":65840,"prefix":null,"prefix_display":null,"first_name":"RACHAEL","nickname":null,"middle_name":null,"last_name":"GALOOB","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}